Morgan Stanley Pfizer Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Pfizer Inc stock. As of the latest transaction made, Morgan Stanley holds 77,971,216 shares of PFE stock, worth $1.94 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares

77,971,216

Previous 77,472,246 0.64%

Holding current value

$1.94 Billion

Previous $2.17 Billion 4.1%

% of portfolio

0.17%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $13.8 Million - $15.7 Million	498,970 Added 0.64%	77,971,216 $2.26 Billion
Q2 2024 Oct 17, 2024	SELL	$25.26 - $29.6 $185 Million - $217 Million	-7,320,593 Reduced 8.63%	77,472,246 $2.17 Billion
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $185 Million - $217 Million	-7,320,593 Reduced 8.63%	77,472,246 $2.17 Billion
Q1 2024 Oct 17, 2024	BUY	$25.89 - $29.73 $190 Million - $218 Million	7,320,593 Added 9.45%	84,792,839 $2.35 Billion
Q1 2024 Aug 16, 2024	BUY	$25.89 - $29.73 $69.5 Million - $79.9 Million	2,686,303 Added 3.27%	84,792,839 $2.35 Billion
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $69.5 Million - $79.9 Million	2,686,303 Added 3.27%	84,792,839 $2.35 Billion
Q4 2023 Aug 16, 2024	BUY	$26.13 - $33.94 $121 Million - $157 Million	4,634,290 Added 5.98%	82,106,536 $2.36 Billion
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $73.7 Million - $95.8 Million	-2,821,266 Reduced 3.32%	82,106,536 $2.36 Billion
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $11.2 Million - $13.1 Million	348,628 Added 0.41%	84,927,802 $2.82 Billion
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $142 Million - $164 Million	3,929,745 Added 4.87%	84,579,174 $3.1 Billion
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $45.3 Million - $59 Million	1,150,068 Added 1.45%	80,649,429 $3.29 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $310 Million - $404 Million	7,419,929 Added 10.29%	79,499,361 $4.08 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $20.5 Million - $25.1 Million	-469,003 Reduced 0.65%	72,079,432 $3.15 Billion
Q2 2022 Oct 27, 2022	BUY	$46.53 - $55.17 $1.17 Billion - $1.39 Billion	25,173,688 Added 53.14%	72,548,435 $3.8 Billion
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.17 Billion - $1.39 Billion	25,173,688 Added 53.14%	72,548,435 $3.8 Billion
Q1 2022 Oct 27, 2022	SELL	$45.75 - $56.69 $1.15 Billion - $1.43 Billion	-25,173,688 Reduced 34.7%	47,374,747 $2.45 Billion
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $14.7 Million - $18.2 Million	320,901 Added 0.68%	47,374,747 $2.45 Billion
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $16.5 Million - $24.5 Million	399,821 Added 0.86%	47,053,846 $2.78 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $1.83 Billion - $2.35 Billion	46,654,025 New	46,654,025 $2.01 Billion

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account